DS
NVO

DRW Securities’s Novo Nordisk NVO Stock Holding History

DRW Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,200
Closed -$361K – 1215
2025
Q1 		$361K Buy
+5,200
New +$429K 0.01% 391
2024
Q4 		– Sell
-7,600
Closed -$905K – 727
2024
Q3 		$905K Buy
+7,600
New +$1.01M 0.03% 298

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

DRW Securities's NVO Position: Q2 2026 in Review

DRW Securities reduced its Novo Nordisk (NVO) stake by 77% in Q2 2026, selling an estimated $930K and leaving 6,628 shares worth $318K. The position accounts for 0.01% of the portfolio, ranked #590.

DRW Securities first reported a position in NVO in Q3 2015 and has held it in 18 quarters since. The position peaked at $10.3M in Q3 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • DRW Securities held 6,628 shares of Novo Nordisk worth $318K as of Q2 2026.
  • DRW Securities sold 21,647 Novo Nordisk shares in Q2 2026, an estimated $930K.
  • Novo Nordisk made up 0.01% of DRW Securities's portfolio in Q2 2026, its #590 holding.
  • DRW Securities first reported a position in Novo Nordisk in Q3 2015 and has held it in 18 quarters since.
  • DRW Securities's Novo Nordisk position peaked at $10.3M in Q3 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.